Cargando…
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
INTRODUCTION: Studies investigating genetic risk factors for susceptibility to rheumatoid arthritis (RA) studied anti-citrullinated peptide antibody (CCP)-positive RA more frequently than anti-CCP-negative RA. One of the reasons for this is the perception that anti-CCP-negative RA may include patien...
Autores principales: | De Rooy, Diederik PC, Willemze, Annemiek, Mertens, Bart, Huizinga, Tom WJ, Van der Helm-van Mil, Annette HM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308115/ https://www.ncbi.nlm.nih.gov/pubmed/22032620 http://dx.doi.org/10.1186/ar3505 |
Ejemplares similares
-
Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2005) -
Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2008) -
Aspects of early arthritis. Definition of disease states in early arthritis: remission versus minimal disease activity
por: van der Helm-van Mil, Annette HM, et al.
Publicado: (2006) -
Expression of citrullin-containing antigens in RA synovium
por: Smeets, TJ, et al.
Publicado: (2001) -
Substitution of the quantitative serological component in the 2010 criteria for RA with qualitative presence of three autoantibodies yields similar performance: response to the article by Regueiro et al.
por: van Dijk, Bastiaan T., et al.
Publicado: (2020)